Shares of other companies:
April 29, 2024 Tesla, Baidu Join Forces for Self-Driving Tech in China
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Facing A Liquidity Crunch; Dilution Ahead?
April 29, 2024
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
HOLX Stock News and Mentions of Hologic, Inc. Stocktwits
Updated: April 30, 2024 (10:17)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Hologic Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Hologic, Inc. (HOLX).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Hologic stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Hologic, Inc. (HOLX)
April 29, 2024 (15:44) / "Zacks Commentary" (by Riya Anand)
How You Should Play Hologic ( HOLX ) Ahead of Q2 Earnings
Hologic's (HOLX) second-quarter 2024 earnings will likely reflect gains from the GYN surgical business and the growing adoption of Panther instruments.
In Article Trend: Somewhat-Bullish
April 29, 2024 (14:00) / "Zacks Commentary" (by Zacks Equity Research)
Si-Bone ( SIBN ) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Si-Bone (SIBN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In Article Trend: Somewhat-Bullish
April 29, 2024 (13:16) / "Zacks Commentary" (by Zacks Equity Research)
Stay Ahead of the Game With Hologic ( HOLX ) Q2 Earnings: Wall Street's Insights on Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Hologic (HOLX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
In Article Trend: Neutral
April 29, 2024 (11:20) / "Zacks Commentary" (by Zacks Investment Research)
The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp
10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp are included in this Analyst Blog.
In Article Trend: Neutral
April 26, 2024 (15:30) / "Zacks Commentary" (by Urmimala Biswas)
3 Medical Products Stocks Set to Beat This Earnings Season
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
In Article Trend: Neutral
April 25, 2024 (14:01) / "Zacks Commentary" (by Zacks Equity Research)
Hologic ( HOLX ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In Article Trend: Somewhat-Bullish
April 25, 2024 (13:00) / "PR Newswire" (by PinkDx)
PINKDX LAUNCHES WITH $40 MILLION SERIES A FINANCING TO DEVELOP DIAGNOSTICS ADDRESSING UNMET MEDICAL NEEDS FOR WOMEN
PINKDX LAUNCHES WITH $40 MILLION SERIES A FINANCING TO DEVELOP DIAGNOSTICS ADDRESSING UNMET ... PR ...
In Article Trend: Neutral
April 24, 2024 (12:50) / "Zacks Commentary" (by Zacks Equity Research)
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
In Article Trend: Somewhat-Bullish
April 22, 2024 (21:45) / "Zacks Commentary" (by Zacks Equity Research)
Hologic ( HOLX ) Stock Drops Despite Market Gains: Important Facts to Note
Hologic (HOLX) reachead $75.36 at the closing of the latest trading day, reflecting a -0.03% change compared to its last close.
In Article Trend: Neutral
April 19, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)
Hologic ( HOLX ) Q2 Earnings Might Rise on GYN Surgical Growth
Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.
In Article Trend: Somewhat-Bullish
April 19, 2024 (13:00) / "Zacks Commentary" (by Zacks Equity Research)
Hologic, Inc. ( HOLX ) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In Article Trend: Somewhat-Bullish
April 18, 2024 (21:31) / "PR Newswire" (by DelveInsight Business Research)
Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness.
In Article Trend: Neutral
April 17, 2024 (15:01) / "Zacks Commentary" (by Zacks Equity Research)
Hologic ( HOLX ) to Report Q2 Earnings: What's in the Cards?
Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic's (HOLX) fiscal second-quarter performance.
In Article Trend: Somewhat-Bullish
April 15, 2024 (21:45) / "Zacks Commentary" (by Zacks Equity Research)
Hologic ( HOLX ) Increases Despite Market Slip: Here's What You Need to Know
Hologic (HOLX) reachead $77.54 at the closing of the latest trading day, reflecting a +0.27% change compared to its last close.
In Article Trend: Neutral
April 13, 2024 (03:33) / "PR Newswire" (by 360iResearch)
STD Testing Market Projected to Reach $14.11 billion by 2030 - Exclusive Report by 360iResearch
PUNE, India, April 12, 2024 /PRNewswire/ -- The report titled "STD Testing Market by Type ( Blood Tests, Lumbar Puncture, Swab Tests ) , Product Type ( Instruments, Reagents & Kits ) , Test Settings, Indication, End-user - Global Forecast 2024-2030" is now available on 360iResearch.com's ...
In Article Trend: Bullish
April 12, 2024 (14:45) / "Zacks Commentary" (by Zacks Equity Research)
Hologic's ( HOLX ) New Launches Aid, Macroeconomic Issues Ail
Hologic's (HOLX) Breast Health segment is gaining from a broad portfolio of solutions for breast cancer care, primarily in the burgeoning spaces of radiology, breast surgery, pathology and treatment.
In Article Trend: Neutral
April 8, 2024 (21:45) / "Zacks Commentary" (by Zacks Equity Research)
Hologic ( HOLX ) Falls More Steeply Than Broader Market: What Investors Need to Know
Hologic (HOLX) concluded the recent trading session at $77.38, signifying a -0.77% move from its prior day's close.
In Article Trend: Somewhat-Bullish
April 8, 2024 (17:26) / "Forbes" (by Chase Feiger)
How This CEO Consumerized Cancer Diagnostics Into A $13B Enterprise
Exact Sciences' ( NDAQ: EXAS ) history is a tale of two halves. Founded in 1995 in Marlborough, Massachusetts, "Exact," as the company is known, went public in 2001 but struggled to find its footing, flirting with delisting.
In Article Trend: Somewhat-Bullish
April 8, 2024 (13:00) / "Zacks Commentary" (by Zacks Equity Research)
Hologic, Inc. ( HOLX ) Is a Trending Stock: Facts to Know Before Betting on It
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In Article Trend: Somewhat-Bullish
April 4, 2024 (09:07) / "GlobeNewswire" (by BioPorto A/S)
Notice convening the Annual General Meeting in BioPorto A/S
April 4, 2024Announcement no. ...
In Article Trend: Neutral
April 3, 2024 (16:10) / "Zacks Commentary" (by Zacks Equity Research)
Will Hologic ( HOLX ) Beat Estimates Again in Its Next Earnings Report?
Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
In Article Trend: Somewhat-Bullish
April 3, 2024 (12:50) / "Zacks Commentary" (by Zacks Equity Research)
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
In Article Trend: Somewhat-Bullish
April 2, 2024 (21:45) / "Zacks Commentary" (by Zacks Equity Research)
Hologic ( HOLX ) Stock Moves -0.05%: What You Should Know
Hologic (HOLX) reachead $76.08 at the closing of the latest trading day, reflecting a -0.05% change compared to its last close.
In Article Trend: Neutral
March 27, 2024 (13:00) / "Zacks Commentary" (by Zacks Equity Research)
Investors Heavily Search Hologic, Inc. ( HOLX ) : Here is What You Need to Know
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In Article Trend: Somewhat-Bullish
March 25, 2024 (21:45) / "Zacks Commentary" (by Zacks Equity Research)
Hologic ( HOLX ) Ascends While Market Falls: Some Facts to Note
Hologic (HOLX) closed at $75.65 in the latest trading session, marking a +0.52% move from the prior day.
In Article Trend: Neutral
March 25, 2024 (14:20) / "Zacks Commentary" (by Zacks Equity Research)
GE HealthCare ( GEHC ) Uses AI Solution to Boost Medical Imaging
GE HealthCare's (GEHC) SonoSAMTrack demonstrates its pliability and applicability in ultrasound image segmentation by using NVIDIA's technology.
In Article Trend: Somewhat-Bullish
March 25, 2024 (13:10) / "Zacks Commentary" (by Zacks Equity Research)
QIAGEN ( QGEN ) Partners With IPPA to Raise TB Screening Awareness
QIAGEN's (QGEN) collaboration with IPPA follows the updated CDC guidelines for TB screening for immigrants in the United States.
In Article Trend: Somewhat-Bullish
March 18, 2024 (21:45) / "Zacks Commentary" (by Zacks Equity Research)
Hologic ( HOLX ) Rises But Trails Market: What Investors Should Know
Hologic (HOLX) concluded the recent trading session at $76.35, signifying a +0.58% move from its prior day's close.
In Article Trend: Somewhat-Bullish
March 15, 2024 (13:00) / "Zacks Commentary" (by Zacks Equity Research)
Here is What to Know Beyond Why Hologic, Inc. ( HOLX ) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
In Article Trend: Somewhat-Bullish
March 12, 2024 (21:45) / "Zacks Commentary" (by Zacks Equity Research)
Hologic ( HOLX ) Stock Declines While Market Improves: Some Information for Investors
In the latest trading session, Hologic (HOLX) closed at $75.64, marking a -0.9% move from the previous day.
In Article Trend: Somewhat-Bullish
March 8, 2024 (07:14) / "Stocknews.com" (by Defense World Staff)
Hologic ( NASDAQ:HOLX ) Stock Rating Lowered by StockNews.com
Hologic ( NASDAQ:HOLX - Get Free Report ) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating in a research note issued on Friday. HOLX has been the subject of a number of other research reports.
In Article Trend: Somewhat-Bullish
March 7, 2024 (16:31) / "Zacks Commentary" (by Zacks Equity Research)
Why Is Waters ( WAT ) Up 7.9% Since Last Earnings Report?
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 6, 2024 (16:15) / "Zacks Commentary" (by Zacks Equity Research)
Hologic's ( HOLX ) BCI Genomic Test Study Outcome Favorable
Hologic's (HOLX) BCI test is the only genomic test that is approved by various national oncology guidelines.
In Article Trend: Neutral
March 4, 2024 (14:00) / "Zacks Commentary" (by Zacks Equity Research)
Is Trending Stock Hologic, Inc. ( HOLX ) a Buy Now?
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In Article Trend: Somewhat-Bullish
March 2, 2024 (07:01) / "Stocknews.com" (by ABMN Staff)
Hologic ( NASDAQ:HOLX ) Upgraded at StockNews.com
Hologic ( NASDAQ:HOLX - Get Free Report ) was upgraded by stock analysts at StockNews.com from a "hold" rating to a "buy" rating in a note issued to investors on Thursday. HOLX has been the topic of a number of other research reports.
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website